Example reporting template
Jump to navigation
Jump to search
PROCEDURE: CT CHEST NON CONTRAST - NODULE PROTOCOL {Used for nodules less than 10 mm; generally fewer than 6 nodules; not diffuse nodules; or for sarcoma metastasis screening.} CLINICAL INDICATION: [Follow up lung nodules*]. COMPARISON: [None*]. TECHNIQUE: [Low-dose helical CT was acquired from lung apices to bases, and reconstructed at 2.5 mm every 1.25 mm, and 1.25 mm every 0.625 mm, without intravenous contrast.] (DFOV = [ ] cm) FINDINGS: Nodules: Nodule: Size: [# x # cm] {if size > 3cm, it's a "mass" and needs staging info} Composition: [ solid | ground-glass | mixed | calcified | fatty | enhancing | cavitation ] Calcification: [none* | benign pattern | indeterminate] {only if Composition = calcified} Location: {lung/lobe/segment} Image location: series # image # Other lung findings: [ ] Airway: [Unremarkable.] Pleura: [No pleural effusion, thickening or pneumothorax.] Thoracic aorta and great vessels: [<Normal in diameter.>] Pulmonary arteries: [<Normal.>] Heart and pericardium: [<Unremarkable.>] Lymph nodes: [<No enlarged thoracic lymph nodes.>] Thoracic spine: [Unremarkable, with normal thoracic vertebral body heights.] Chest wall: [Unremarkable.] Visualized upper abdomen: [Unremarkable.] IMPRESSION: 1. [< >]. Recommendations for Follow-up and Management of Indeterminate Lung Nodules Detected Incidentally on Nonscreening CT (Adapted from the Fleischner Society Statement on CT of Small Pulmonary Nodules (Radiology 2005;237:395-400) Nodule Low-Risk Patient High-Risk Patient Size < 4 mm no follow up needed follow up CT at 12 months if unchanged, no follow up 4-8 mm follow up CT at 6, 12 and 24 months if no change, further follow up > 8 mm contrast enhanced CT, PET and/or biopsy, OR watchful waiting: follow up CT at 3, 9 & 24 months Notes: diameter = average width; high risk is defined as a history of smoking or other know risk factors for lung cancer; low risk is defined as minimal or absent history of smoking or other known risk factors; caveat: nodules with a ground glass component may require longer follow up to exclude indolent adenocarcinoma